Following years of hiccups and false begins, seed-to-sale monitoring is coming to New York’s $1.5 billion hashish market in December, regulators stated Monday.
Dec. 17 is when all New York operators have to be utilizing the system, with all stock tagged two days prior, in keeping with a Sept. 22 Workplace of Hashish Administration (OCM) bulletin.
In response to OCM, main deadlines embrace:
- Nov. 7, when Metrc credentialing begins and operators can begin ordering ID tags.
- Nov. 21, when companies can begin inputting key information into Metrc.
- Dec. 5, when labs add outcomes for product already examined.
- Dec. 15, when all stock have to be tagged in Metrc.
- Dec. 17, when all licensees have to be within the system.
After a tortuous begin marred by lawsuits and bureaucratic snafus, New York launched hashish gross sales in December 2022.
Nonetheless, in distinction to different markets, New York’s market opened with out a seed-to-sale track-and-trace system in place.
Observers and regulators alike have fingered the dearth of such oversight because the “soiled secret” on the coronary heart of ongoing diversion and inversion points.
Supporters say that it will likely be harder for illicit hashish to be bought in New York shops with a functioning track-and-trace system.
New York missed a number of self-imposed deadlines to start track-and-trace.
Most not too long ago, seed-to-sale monitoring was supposed to start in August.
That was kiboshed on the final minute when BioTrack, New York’s chosen vendor, bought its authorities contracts to trade chief Metrc in a deal introduced Aug. 5.
With New York, Lakeland, Florida-based Metrc contracts with 30 states for mandated track-and-trace programs.
The system isn’t with out its critics.
In an ongoing lawsuit, a former government vice chairman with the corporate alleged that diversion continues regardless of Metrc.